Senior equity researcher with extensive experience analyzing companies, industries, and market trends. Focused on facts, fundamentals, and long-term.

New York
Small caps are bucking a weak tape—but the second move matters more than the first. $WHLR: Above $6.90, watch $7.50–8.00. Below $6.20, momentum fades. $VTGN: Clear $0.43 for $0.46–0.48. Risk below $0.38. $DCOY: Reclaim $4.80 for a $5.20–5.50 retest. Watch $4.30. $TLSI: FDA clearance. Above $5.50, target $5.80–6.00. Risk below $5.00. $BFRG: Insider buying. Above $0.80 opens $0.85–0.90. Watch $0.70. Volume needs to confirm. No chasing failed breakouts.
I'll only say this once. Small caps are heating up. Here are five price setups I'm watching: $WHLR: Above $5.70, watch $6.20–6.80. $VTGN: Clear $0.48, target $0.52–0.58. $DCOY: Break $4.10, watch $4.40–4.70. $TLSI: Above $5.80, target $6.00–6.30. $BFRG: Clear $0.75, watch $0.80–0.85. Volume needs to confirm. A failed breakout changes the setup fast.
500
The Fed’s inflation problem is bigger than oil. Richmond Fed President Tom Barkin says the U.S. economy is firming, while price pressures extend well beyond energy and tariffs. After last week’s 25-basis-point rate hike, he sees inflation as the bigger risk. For Wall Street, the question is whether sticky inflation keeps rates higher for longer.
92
I'll only say this once. Small caps are heating up. Here are five price setups I'm watching: $WHLR: Above $5.70, watch $6.20–6.80. $VTGN: Clear $0.48, target $0.52–0.58. $DCOY: Break $4.10, watch $4.40–4.70. $TLSI: Above $5.80, target $6.00–6.30. $BFRG: Clear $0.75, watch $0.80–0.85. Volume needs to confirm. A failed breakout changes the setup fast.
730
Another wild session in small caps. 👀 $DCOY delivered a massive momentum move, while $VKTX surged on positive VK2735 obesity-drug data. $GRML kept the Greenland trade in focus, and $FLNA attracted fresh speculative volume. $QNME stayed on the radar, but not every setup deserves a victory lap. The takeaway? Catalysts bring attention, volume brings momentum, and price action tells us whether buyers are actually sticking around. Patience still pays.
$VKTX — Fresh obesity-drug data is bringing serious attention back to the stock. $GRML — Still riding the Greenland and critical-minerals narrative after yesterday's massive move. $QNME — Quantum and AI speculation. Watching whether volume can support another leg higher. $FLNA — High-risk biotech setup. Needs buyers to show up and defend key levels. $DCOY — Speculative momentum watch. Liquidity and confirmation are everything here. I'm watching VWAP, opening-range highs, and volume as the session develops. A clean reclaim with sustained buying could open the door for another move, but chasing extended candles is how traders get trapped. Which ticker are you watching into the afternoon?
598
$QQQ is leading as AI and tech keep the momentum alive, while $SPY needs broader participation. Oil pulling back is helping growth stocks, but the real test is whether buyers hold VWAP and push into the close. Watching semis and volume for confirmation. Let the tape do the talking.
124
Donald Trump's UN speech just put geopolitics right back at the center of the market. His hard line on Iran keeps oil and inflation risks in play, while any real diplomatic progress around the Strait of Hormuz could send crude lower fast. Meanwhile, traders are already looking ahead to the Trump-Xi meeting for clues on AI, chips and trade. As for stocks, I’m watching $XOM $CVX for oil moves, $UAL $DAL if fuel costs ease, and $NVDA $AMD $AVGO for any China/AI headlines. The key now is simple: watch how oil, yields and semis react — not just what gets said at the podium.
1
1
170
$VKTX — Fresh obesity-drug data is bringing serious attention back to the stock. $GRML — Still riding the Greenland and critical-minerals narrative after yesterday's massive move. $QNME — Quantum and AI speculation. Watching whether volume can support another leg higher. $FLNA — High-risk biotech setup. Needs buyers to show up and defend key levels. $DCOY — Speculative momentum watch. Liquidity and confirmation are everything here. I'm watching VWAP, opening-range highs, and volume as the session develops. A clean reclaim with sustained buying could open the door for another move, but chasing extended candles is how traders get trapped. Which ticker are you watching into the afternoon?
1
1
1
1,015
ENERGY vs. AI Two sectors I’m keeping a close eye on right now. Oil & Energy: $XOM $CVX $COP AI & Semiconductors: $NVDA $AMD $INTC $AVGO $AMAT $LRCX Energy is all about crude prices, supply, and geopolitical headlines. AI is a different story. From GPUs and networking to chipmaking equipment, the infrastructure buildout goes well beyond just $NVDA. Different sectors. Different catalysts. Same thing I’m watching: where is the money actually flowing? Which sector are you putting your money on right now — ENERGY or AI?
131
Quick recap on this morning’s six small caps. $GRML and $GLND were the clear standouts as the Greenland/critical-minerals theme caught fire. $BTTC kept strong momentum, while $LOBO and $CRML also followed through with heavy volume and solid gains. $CUE was the reminder that a catalyst alone isn’t enough — it reversed hard after the open and failed to hold the setup. Overall, the watchlist delivered strong action, but the lesson stays the same: don’t chase the premarket gap. Let volume, VWAP and the opening range confirm the move first.
Small caps are wide awake this morning. $GLND and $GRML are leading the tape as the Greenland security/critical-minerals theme catches fire, while $CRML is getting dragged into the same rare-earth trade. $CUE has the cleanest biotech catalyst after positive Phase 2 data, and $LOBO is moving off improved H1 results plus its AI angle. $BTTC is the wild card — huge premarket momentum, but much more speculative. $GLND $GRML $BTTC $CUE $CRML $LOBO I’m not chasing the first spike. I want to see which names can hold VWAP, defend the opening range, and keep volume elevated after the bell. If that happens, a few of these could stay very active all morning.
542
AI money is coming back fast. $AMD just crossed the $1T mark. $INTC is ripping double digits. $NVDA is confirming the broader AI bid. The market spent weeks questioning AI spending. Today, buyers are answering with their wallets. I’m watching whether this momentum actually holds into the close.
1
161
US-China talks made some progress, but no big trade breakthrough yet. The two sides are moving toward a formal AI safety dialogue, while tariffs, critical minerals and major purchases remain unresolved. Semis, rare earths, agriculture and $BA are still worth watching closely.
153
Small caps are wide awake this morning. $GLND and $GRML are leading the tape as the Greenland security/critical-minerals theme catches fire, while $CRML is getting dragged into the same rare-earth trade. $CUE has the cleanest biotech catalyst after positive Phase 2 data, and $LOBO is moving off improved H1 results plus its AI angle. $BTTC is the wild card — huge premarket momentum, but much more speculative. $GLND $GRML $BTTC $CUE $CRML $LOBO I’m not chasing the first spike. I want to see which names can hold VWAP, defend the opening range, and keep volume elevated after the bell. If that happens, a few of these could stay very active all morning.
1
872
US-China talks are back in focus. AI, tariffs and critical minerals are the real market tells here. Any concrete progress could quickly spill into semis, rare-earth names, industrials, agriculture and $BA. The headline matters — but the details and follow-through will matter more.
155
10Y above 5%. Fed just hiked. Oil still over $100. And the Nasdaq still finished the week green. That’s a weird mix. (Reuters) So what gives first — yields, tech, or inflation? Curious what everyone’s watching next week.
104
Elon Musk has made a bold prediction. While artificial intelligence can undoubtedly boost productivity, mere hype is far from enough to double the U.S. GDP growth rate within a year; achieving that requires tangible adoption, investment, and measurable output growth. Despite the immense opportunities, I remain cautious about the timeline for realizing this goal.
1
102
$IMCC, $MEDS, $SSM were good reminders that strong momentum setups often start with confirmation, not prediction. Each showed the basic ingredients we look for: expanding volume, a break from the prior range, and enough follow-through to confirm real market participation. $IMCC reached an intraday high of $8.57, while $SSM pushed to $3.15. $MEDS also saw a sharp move, but none of them offered an easy straight-line trade. That’s why execution mattered more than the headline move. Wait for the setup, respect the volume, manage risk into strength, and don’t confuse a good trade with a reason to overstay.
Three names are getting serious attention right now: $IMCC, $MEDS , $SSM. $IMCC is the pure momentum play. It’s ripping on huge premarket volume without a fresh headline, so this looks more like low-float speculation than a fundamental reset. If volume sticks, it can stay wild. $MEDS actually has news behind the move. The Helomics deal adds AI cancer diagnostics and oncology exposure, while management says a recent settlement could wipe roughly $19M in liabilities. After that massive run, volatility is still the main risk. $SSM is trading on renewed interest around the proposed Sports One combination. With this kind of volume, hype can squeeze it fast. Three hot tickers. Plenty of upside potential — but none of these are sleepy trades.
497
End of an era at Berkshire Hathaway. Warren Buffett is stepping away from the chairman role and becoming Chairman Emeritus, with Howard Buffett taking over as chairman while Greg Abel continues running the business as CEO. Berkshire itself framed the split pretty clearly: Abel runs the company, Howard protects the culture and values. (Berkshire Hathaway) Honestly, that feels very Buffett. No dramatic handoff. No attempt to copy the past. Just put the right people in the right seats and protect what made Berkshire different in the first place. After six decades, that might be the most Buffett-style exit possible. #WarrenBuffett #BerkshireHathaway
105
$TEM is quickly becoming one of the cleaner AI-healthcare momentum stories on my board. The stock ripped nearly 15% Thursday, and this isn’t just hype. Tempus is getting real attention from Cathie Wood’s ARK, while investors are also leaning into improving reimbursement potential for its cancer-testing business. (Barron's) Fundamentally, the story has more weight than a typical AI trade: Q2 revenue grew 22%, oncology volume rose 31%, and management raised 2026 revenue guidance to roughly $1.6B. (Tempus AI) The broader tape is helping too — tech and AI sentiment has improved as oil and Treasury yields eased. (Reuters) My read: $80–82 is the key battle zone. Hold that area and momentum stays interesting. Lose it, and I’d rather wait for the next clean setup. $TEM #AI #Healthcare #Stocks
124